MedTrace Logo

Dietary Supplement With and Without a Probiotic and/or Antibiotic

NCT05141903 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 92

Last updated 2025-02-17

Study results available
· View outcomes & findings →

Summary

Complex oligosaccharides can alter the gut microbiome by aiding in the growth of certain organisms, and possibly, inhibiting others. The synergy with a probiotic may enhance gastrointestinal colonization.

Conditions

  • Healthy Adults

Interventions

DIETARY_SUPPLEMENT

Antibiotic

Vancomycin (250 mg/dose), Metronidazole (500 mg/dose)

DIETARY_SUPPLEMENT

HMO Concentrate

Concentrated milk fortifiers from donor human milk

DIETARY_SUPPLEMENT

Probiotic

B. infantis

DIETARY_SUPPLEMENT

Food Supplement

Synthetic powder containing 2'-fucosyllactose (2'-FL) and lactoneotetraose (LNnT)

Sponsors & Collaborators

  • Prolacta Bioscience

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-21
Primary Completion
2022-05-23
Completion
2022-06-09

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05141903 on ClinicalTrials.gov